Branched-chain amino acid supplements reduced ascites and increased the quality of life in a patient with liver cirrhosis: A case report

Molecular Medicine Reports

Volumn 2, Issue 6, 2009, Pages 977-981

  Itou, Minoru ^a   Kawaguchi, Takumi ^a,b   Taniguchi, Eitaro ^a   Oku, Yuichiro ^a   Fukushima, Nobuyoshi ^a   Ando, Eiji ^a   Oriishi, Tetsuharu ^a   Uchida, Yuki ^a   Otsuka, Momoka ^a   Tanaka, Suiko ^a   Iwasaki, Shoko ^a   Torii, Mari ^a   Yoshida, Kiyomi ^a   Adachi, Yuko ^a   Suga, Mariko ^a   Yoshiyama, Manami ^a   Ibi, Ryoko ^a   Akiyama, Yoshiko ^a   Takakura, Machiko ^a   Mitsuyama, Keiichi ^a   Tsuruta, Osamu ^a   Sata, Michio ^a,b   more..

^a KURUME UNIVERSITY HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ascites; Branched chain amino acids; Liver cirrhosis

Indexed keywords

ARGININE; BRANCHED CHAIN AMINO ACID; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

ADULT; ARTICLE; ASCITES; CASE REPORT; DIET SUPPLEMENTATION; DIET THERAPY; ECHOGRAPHY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; JAPANESE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; NUTRITIONAL STATUS; PERIPHERAL EDEMA; PROTEIN CALORIE MALNUTRITION; PROTEIN INTAKE; QUALITY OF LIFE; SHORT FORM 36; UMBILICAL HERNIA;

EID: 73649103129     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000201     Document Type: Article

References (22)

1. Miwa Y and Moriwaki H: Nocturnal energy and BCAA supplementation in patients with liver cirrhosis. Hepatol Res 30S: 63-66, 2004.
2. Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H and Shiraki M: Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 313: 405-409, 2004.
3. Sato S, Watanabe A, Muto Y, et al: Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study). Hepatol Res 31: 232-240, 2005.
4. Fukuda K, Yao H, Murai K, Ibayashi S and Fujishima M: Long-term treatment of portosystemic encephalopathy with oral branched-chain amino acids - a case report. Fukuoka Igaku Zasshi 90: 464-469, 1999.
5. Higuchi K, Shimizu Y, Nambu S, et al: Effects of an infusion of branched-chain amino acids on neurophysiological and psychometric testings in cirrhotic patients with mild hepatic encephalopathy. J Gastroenterol Hepatol 9: 366-372, 1994.
6. Habu D, Nishiguchi S, Nakatani S, et al: Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial. Hepatol Res 25: 312-318, 2003.
7. Suzuki K, Suzuki K, Koizumi K, et al: Measurement of serum branched-chain amino acids to tyrosine ratio level is useful in a prediction of a change of serum albumin level in chronic liver disease. Hepatol Res 38: 267-272, 2008.
8. Plauth M, Cabre E, Riggio O, et al: ESPEN Guidelines on Enteral Nutrition: Liver Disease. Clin Nutr 25: 285-294, 2006.
9. Nakaya Y, Okita K, Suzuki K, et al: BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 23: 113-120, 2007.
10. Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C and Avruch J: Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 273: 14484-14494, 1998.
11. Ijichi C, Matsumura T, Tsuji T and Eto Y: Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 303: 59-64, 2003.
12. Nishitani S and Takehana K: Pharmacological activities of branched-chain amino acids: augmentation of albumin synthesis in liver and improvement of glucose metabolism in skeletal muscle. Hepatol Res 30S: 19-24, 2004.
13. Spiess A, Mikalunas V, Carlson S, Zimmer M and Craig RM: Albumin kinetics in hypoalbuminemic patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 20: 424-428, 1996.
14. Fukuhara S, Bito S, Green J, Hsiao A and Kurokawa K: Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 51: 1037-1044, 1998.
15. Kawaguchi T, Taniguchi E, Itou M, et al: Appearance-specific satiety increases appetite and quality of life in patients with metastatic liver tumor: a case report. Kurume Med J 53: 41-46, 2006.
16. Marchesini G, Bianchi G, Merli M, et al: Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124: 1792-1801, 2003.
17. Kawamura N, Nakajima H and Takashi SI: Administration of granulated BCAA and quality of life. Hepatol Res 30S: 42-45, 2004.
18. Saab S, Ibrahim AB, Shpaner A, et al: MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 11: 218-223, 2005.
19. Watanabe A: Cerebral changes in hepatic encephalopathy. J Gastroenterol Hepatol 13: 752-760, 1998.
20. Arguedas MR, DeLawrence TG and McGuire BM: Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 48: 1622-1626, 2003.
21. Yamamoto M, Iwasa M, Matsumura K, et al: Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World J Gastroenterol 11: 6792-6799, 2005.
22. Immer FF, Lippeck C, Barmettler H, et al: Improvement of quality of life after surgery on the thoracic aorta: effect of antegrade cerebral perfusion and short duration of deep hypothermic circulatory arrest. Circulation 110: II250-II255, 2004.